Clinical Trial Update: Heparin Induced Thrombocytopenia: Pharmacoeconomics

View source ↗

Summary

This completed clinical trial update reports on the pharmacoeconomic analysis and cost implications of managing heparin-induced thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Heparin Induced Thrombocytopenia (HIT) | Status: COMPLETED